CSIMarket
Eli Lilly And Company  (LLY)
Other Ticker:  
 
 
Price: $249.2400 $1.20 0.484%
Day's High: $250.93 Week Perf: -4.87 %
Day's Low: $ 247.89 30 Day Perf: -0.03 %
Volume (M): 175 52 Wk High: $ 275.87
Volume (M$): $ 43,638 52 Wk Avg: $216.30
Open: $249.44 52 Wk Low: $143.13



 Market Capitalization (Millions $) 227,008
 Shares Outstanding (Millions) 911
 Employees 33,625
 Revenues (TTM) (Millions $) 27,759
 Net Income (TTM) (Millions $) 5,972
 Cash Flow (TTM) (Millions $) 193
 Capital Exp. (TTM) (Millions $) 1,473

Eli Lilly And Company
We discover, develop, manufacture, and sell products in one significant business segment—pharmaceutical products. Operations of our animal health business segment are not material to our financial statements. We manufacture and distribute our products through owned or leased facilities in the United States, Puerto Rico, and 17 other countries. Our products are sold in approximately 140 countries.


   Company Address: Lilly Corporate Center Indianapolis 46285 IN
   Company Phone Number: 276-2000   Stock Exchange / Ticker: NYSE LLY
   LLY is expected to report next financial results on February 16, 2022. Next quarterly dividend pay out on December 10, 2021.


Customers Net Income grew by LLY's Customers Net Profit Margin grew to

23.04 %

4.47 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
JNJ   -0.64%    
BMY   -2.75%    
PFE        1.39% 
ABT        0.69% 
MRK   -5.95%    
ABBV   -0.5%    
• View Complete Report
   



Hqda Elderly Life Network Corp

Break-even, Sales more than Double

In the most recent fiscal period Hqda Elderly Life Network Corp reached break-even of $0.00 per share compared to $-0.00 a year ago and from $-0.00 per share from the previous quarter.

Sales increased sharply by 275.51% to $0.14 millions from $0.04 millions in the same quarter a year ago and sequentially Sales advanced by 10.99 % from $0.13 millions.

Aerovate Therapeutics Inc

Deficit Bigger Than a Year Ago but Revenues Unchanged

In the fiscal third quarter of 2021 Aerovate Therapeutics Inc loss increased of $-0.26 per share compared to $-0.00 a year ago and improved from $-23.80 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.04 millions in the same quarter a year ago and sequentially from $0.00 millions.

Cocrystal Pharma Inc

Logged a Loss but Revenues Unchanged

In the third quarter of 2021 Cocrystal Pharma Inc lost money of $-0.04 per share compared to $-0.05 a year ago and from $-0.04 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.49 millions in the same quarter a year ago and sequentially from $0.00 millions.

Yew Bio pharm Group Inc

Deficit Widen, Topline Tumbles

Yew Bio Pharm Group Inc reported disastrous third quarter of 2021 earnings season, where Sales faded by -98.94% to $0.11 millions and loss per share has widen at $-0.03, from the same quarter a year ago.

from the preceding quarter from $-0.01 per share, by -99.26% from $14.84 millions.

Fg Financial Group Inc

Fg Financial Group Inc announced financial time frame ending Sep 30 2021 operating shortfall of $-4.593 millions

For the financial time frame ending Sep 30 2021 Fg Financial Group Inc lost money at $-1.08 per share, compared to results of $-1.69 per share a year ago quarter, In the previous quarter company realized $-0.13 per share.

from $6.38 millions in preceding quarter, increased losses from $-0.13 per share.






 

Eli Lilly's Segments
 
Neurosciences
 Segment    14.61 % of total Revenue
Endocrinology
 Segment    36.02 % of total Revenue
Oncology
 Segment    17.37 % of total Revenue
Animal health
 Segment    15.7 % of total Revenue
Cardiovascular
 Segment    15.32 % of total Revenue
Other pharmaceutical
 Segment    0.98 % of total Revenue
Zyprexa
 Segment    4.8 % of total Revenue
Humulin
 Segment    6.39 % of total Revenue
Humalog
 Segment    14.21 % of total Revenue
Evista
 Segment    1.17 % of total Revenue
Cymbalta
 Segment    4.9 % of total Revenue
Strattera
 Segment    3.97 % of total Revenue
Alimta
 Segment    12.67 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Eli Lilly does not provide revenue guidance.

Earnings Outlook
Fg Financial Group Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 51.93 %
Europe 25.62 %
Other foreign countries 22.44 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CPRT's Profile

Stock Price

CPRT's Financials

Business Description

Fundamentals

Charts & Quotes

CPRT's News

Suppliers

CPRT's Competitors

Customers & Markets

Economic Indicators

CPRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071